Concepedia

Ivor Royston

IR

68

Publications

6.7K

Citations

35

H-Index

1970

Active since

Affiliations

University of California San Diego(Current)

Sidney Kimmel Cancer Center

University of California San Diego Medical Center

United States Department of Veterans Affairs

University of Colorado Denver

Ivor Royston is an author at University of California San Diego specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1970–2023

68

Publications

68

IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

David G. Maloney, Antonio J Grillo-López, Christine A. White et al. · Blood · 1997 · 1.7K citations

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.

DG Maloney, A.J. Grillo-López, David Bodkin et al. · Journal of Clinical Oncology · 1997 · 636 citations

Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.

Ivor Royston, John A. Majda, Stephen M. Baird et al. · The Journal of Immunology · 1980 · 421 citations

, , +17

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.

Habib Fakhrai, Oliver Dorigo, Daniel L. Shawler et al. · Proceedings of the National Academy of Sciences · 1996 · 338 citations · Full text

Clinical Importance of Myeloid Antigen Expression in Adult Acute Lymphoblastic Leukemia

Robert E. Sobol, Rosemarie Mick, Ivor Royston et al. · New England Journal of Medicine · 1987 · 320 citations

Rows per page

1–5 of 68